MICHELLE TYSER: Open Payments
NPI 1083698518 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 25 payments from 13 companies in 2025. Trend: 2023 $554 · 2024 $887 · 2025 $645
Food & beverage: $496Education: $149
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 5 | $139 |
| Grifols USA, LLC | 5 | $111 |
| GENZYME CORPORATION | 3 | $94 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Tactile Systems Technology Inc | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Verona Pharma, Inc. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Insmed, Inc. | 1 | $27 |
| Viatris Specialty LLC | 1 | $21 |
Products named: XYWAV, Prolastin-C Liquid, DUPIXENT, WAYRILZ, Flexitouch Plus, GLASSIA, Ohtuvayre, Arikayce.
Industry payments across NE — which companies pay providers there.
